Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab

Immune checkpoint blockade is an emerging anticancer strategy, and Nivolumab is a human mAb to PD-1 that is used in the treatment of a number of different malignancies, including non-small cell lung cancer (NSCLC), kidney cancer, urothelial carcinoma and melanoma. Although the use of Nivolumab prolo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Nardone, Valerio, Tini, Paolo, Pastina, Pierpaolo, Botta, Cirino, Reginelli, Alfonso, Carbone, Salvatore Francesco, Giannicola, Rocco, Calabrese, Grazia, Tebala, Carmela, Guida, Cesare, Giudice, Aldo, Barbieri, Vito, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, Cappabianca, Salvatore, Capasso, Rosanna, Luce, Amalia, Caraglia, Michele, Mazzei, Maria Antonietta, Pirtoli, Luigi, Correale, Pierpaolo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6956423/
https://ncbi.nlm.nih.gov/pubmed/31966081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.11220
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller